NCT05787795Recruiting
Identifying and Characterizing Preclinical MS
Source: ClinicalTrials.gov · Last updated 27 Aug 2026
Brief summary (registry, in English)
The purpose of this research study is to try and identify risk factors and biologic changes that suggest that someone may go on to develop multiple sclerosis before a person has shown any symptoms of the disease.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 1000 (estimated)
- First submitted
- 15 Mar 2023
- Start date
- 21 Jun 2022
- Primary completion date
- 30 Jun 2032
- Lead sponsor
- Yale University
- Diseases
- Multiple sclerosis
- NCT number
- NCT05787795
What you commit to
- Study type: Observational
- Planned participants: 1000
- From 21 Jun 2022 to the primary completion date, 30 Jun 2032
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Ongoing treatment with immunosuppressive medications
Other illness
- Diagnosis of multiple sclerosis or any ongoing, systemic autoimmune disease
Other
- Currently pregnant
Who the study is looking for
- Age 18+
- Having one or more risk factors for multiple sclerosis, including one or more of the below:
- Individuals known to have a radiologically isolated syndrome
- Individuals with a family history of multiple sclerosis (first degree family member)
- Individuals with personal risk factors, which are known to include smoking, obesity, Epstein Barr virus infections, Vitamin D deficiency, genetic risk score
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Yale University Coordinator of this site? Confirm its status | North Haven | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.